New Method to Detect Inflammation Developed
Researchers have developed a way to detect inflammation through antibodies, potentially enabling blood tests for disease-specific biomarkers.
Read MorePosted by Chris Wolski | Feb 6, 2025 | Diagnostic Technologies |
Researchers have developed a way to detect inflammation through antibodies, potentially enabling blood tests for disease-specific biomarkers.
Read MorePosted by Chris Wolski | Feb 4, 2025 | Dementias & Alzheimer’s |
The use of the PrecivityAD2 blood biomarker test significantly improved clinicians’ confidence in diagnosing Alzheimer’s disease.
Read MorePosted by Chris Wolski | Feb 4, 2025 | Breast |
Roche’s PATHWAY anti-HER2/neu (4B5) test has received FDA approval to ID patients with HR-positive, HER2-ultralow metastatic breast cancer.
Read MorePosted by Andy Lundin | Feb 4, 2025 | Kidney Disease, Point-of-Care |
Carna Health is revolutionizing CKD detection by integrating AI-driven analytics with real-time, point-of-care (POC) testing.
Read MorePosted by Andy Lundin | Feb 3, 2025 | Prostate |
Lynx Dx announced at-home availability of a urine-based prostate cancer test that eliminates the need for a digital rectal exam.
Read More